Long-term comparative effectiveness and safety of dabigatran, rivaroxaban, apixaban and edoxaban in patients with atrial fibrillation: A nationwide cohort study

• Main Authors: Maxim Grymonprez (Author), Tine L. De Backer (Author), Xander Bertels (Author), Stephane Steurbaut (Author), Lies Lahousse (Author)
• Formato: Livro
• Publicado em: Frontiers Media S.A., 2023-02-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Background: Although non-vitamin K antagonist oral anticoagulants (NOACs) are recommended over vitamin K antagonists (VKAs) in atrial fibrillation (AF) management, direct long-term head-to-head comparisons are lacking. Therefore, their risk-benefit profiles were investigated compared to VKAs and bet...